Profil
Chandru Jaswant Chawla is currently the Chief Executive Officer and Director at Cipla BioTec Ltd.
He previously served as the Non-Executive Chairman at Cipla Health Ltd.
Aktive Positionen von Chandru Jaswant Chawla
| Unternehmen | Position | Beginn |
|---|---|---|
Cipla BioTec Ltd.
 Cipla BioTec Ltd. Pharmaceuticals: MajorHealth Technology Cipla BioTec Pvt Ltd. manufactures pharmaceutical products. It focuses on research, development, manufacturing and marketing of biosimilars, in the fields of cancer, auto-immune diseases, respiratory diseases and diabetes. The firm products include CBT 124, CBT 127 and CBT 128. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Salcette, India. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Chandru Jaswant Chawla
| Unternehmen | Position | Ende |
|---|---|---|
Cipla Health Ltd.
 Cipla Health Ltd. Pharmaceuticals: MajorHealth Technology Cipla Health Ltd. develops drugs. It offers products under the brand name include Nicotex, Active immuno boosters, Active women daily calcium and cofsils lozenge, Cofsils cough drops, Cofsils natural ough syrup, Nicogum and Fibocare. The company was founded in August 2015 and is headquartered in Mumbai, India. | Vorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Cipla Health Ltd.
Cipla Health Ltd. Pharmaceuticals: MajorHealth Technology Cipla Health Ltd. develops drugs. It offers products under the brand name include Nicotex, Active immuno boosters, Active women daily calcium and cofsils lozenge, Cofsils cough drops, Cofsils natural ough syrup, Nicogum and Fibocare. The company was founded in August 2015 and is headquartered in Mumbai, India. | Health Technology |
Cipla BioTec Ltd.
Cipla BioTec Ltd. Pharmaceuticals: MajorHealth Technology Cipla BioTec Pvt Ltd. manufactures pharmaceutical products. It focuses on research, development, manufacturing and marketing of biosimilars, in the fields of cancer, auto-immune diseases, respiratory diseases and diabetes. The firm products include CBT 124, CBT 127 and CBT 128. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Salcette, India. | Health Technology |
